Cardiovascular risk factors and diseases in women undergoing hysterectomy with ovarian conservation

Menopause

Volumn 23, Issue 2, 2016, Pages 121-128

  Laughlin Tommaso, Shannon K ^a   Khan, Zaraq ^a   Weaver, Amy L ^a   Schleck, Cathy D ^a   Rocca, Walter A ^a   Stewart, Elizabeth A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cardiovascular disease; Epidemiology; Hysterectomy; Leiomyomas; Ovarian conservation; Stroke

Indexed keywords

ADULT; ARTICLE; CANCER SURGERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDOMETRIOSIS; ENDOMETRIUM CANCER; FEMALE; GROUPS BY AGE; HEART DISEASE; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYSTERECTOMY; INFLAMMATORY DISEASE; LEIOMYOMA; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MENSTRUATION DISORDER; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; ORGAN PRESERVATION; OVARIAN CONSERVATION; OVARIECTOMY; OVARY POLYCYSTIC DISEASE; PELVIC ORGAN PROLAPSE; PREGNANCY COMPLICATION; TREATMENT INDICATION; UTERINE CERVIX CARCINOMA IN SITU; UTERUS PROLAPSE; AGE; CARDIOVASCULAR DISEASES; CAUSALITY; COMORBIDITY; MINNESOTA; MYOCARDIAL INFARCTION; RISK FACTOR; STATISTICS AND NUMERICAL DATA; STROKE; WOMEN'S HEALTH;

ADULT; AGE FACTORS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CAUSALITY; COMORBIDITY; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; MINNESOTA; MYOCARDIAL INFARCTION; RISK FACTORS; STROKE; WOMEN'S HEALTH;

EID: 84959098635     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0000000000000506     Document Type: Article

References (43)

1. Mosca L, Banka CL, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. J Am Coll Cardiol 2007; 49: 1230-1250
2. Lewis BG, Halm EA, Marcus SM, Korenstein D, Federman AD. Preventive services use among women seen by gynecologists, general medical physicians, or both. Obstet Gynecol 2008; 111: 945-952
3. Henderson JT, Weisman CS, Grason H. Are two doctors better than one? Women's physician use, and appropriate care. Womens Health Issues 2002; 12: 138-149
4. Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review, and meta-analysis. Lancet 2009; 373: 1773-1779
5. Ehrenthal DB, Catov JM. Importance of engaging obstetrician/gynecologists in cardiovascular disease prevention. Curr Opin Cardiol 2013; 28: 547-553
6. Settnes A, Andreasen AH, Jørgensen T. Hypertension is associated with an increased risk for hysterectomy: a Danish cohort study. Eur J Obstet Gynecol Reprod Biol 2005; 122: 218-224
7. Settnes A, Jørgensen T. Hypertension, and hysterectomy in Danish women. Obstet Gynecol 1998; 92: 274-280
8. Matthews KA, Gibson CJ, El Khoudary SR, Thurston RC. Changes in cardiovascular risk factors by hysterectomy status with, and without oophorectomy: Study of Women's Health Across the Nation. J Am Coll Cardiol 2013; 62: 191-200
9. Gibson CJ, Thurston RC, El Khoudary SR, Sutton-Tyrrell K, Matthews KA. Body mass index following natural menopause, and hysterectomy with, and without bilateral oophorectomy. Int J Obes (Lond) 2013; 37: 809-813
10. Pansini F, Bonaccorsi G, Calisesi M, et al. Influence of spontaneous, and surgical menopause on atherogenic metabolic risk. Maturitas 1993; 17: 181-190
11. Kritz-Silverstein D, Barrett-Connor E, Wingard DL. Hysterectomy, oophorectomy, and heart disease risk factors in older women. Am J Public Health 1997; 87: 676-680
12. Parker WH, Broder MS, Chang E, et al. Ovarian conservation at the time of hysterectomy, and long-term health outcomes in the Nurses' Health Study. Obstet Gynecol 2009; 113: 1027-1037
13. Parker WH, Jacoby V, Shoupe D, Rocca W. Effect of bilateral oophorectomy on women's long-term health. Womens Health (Lond Engl) 2009; 5: 565-576
14. Rocca WA, Grossardt BR, Shuster LT, Stewart EA. Hysterectomy, oophorectomy, estrogen, and the risk of dementia. Neurodegener Dis 2012; 10: 175-178
15. Shuster LT, Gostout BS, Grossardt BR, Rocca WA. Prophylactic oophorectomy in premenopausal women, and long-term health. Menopause Int 2008; 14: 111-116
16. Babalola EO, Bharucha AE, Melton LJ III, et al. Utilization of surgical procedures for pelvic organ prolapse: a population-based study in Olmsted County, Minnesota, 1965-2002. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19: 1243-1250
17. Babalola EO, Bharucha AE, Schleck CD, Gebhart JB, Zinsmeister AR, Melton LJ III. Decreasing utilization of hysterectomy: a population-based study in Olmsted County, Minnesota, 1965-2002. Am J Obstet Gynecol 2007; 196: 214.e1-214.e7
18. Blandon RE, Bharucha AE, Melton LJ III, et al. Incidence of pelvic floor repair after hysterectomy: a population-based cohort study. Am J Obstet Gynecol 2007; 197: 664.e1-664.e7
19. Blandon RE, Bharucha AE, Melton LJ III, Schleck CD, Zinsmeister AR, Gebhart JB. Risk factors for pelvic floor repair after hysterectomy. Obstet Gynecol 2009; 113: 601-608
20. Melton LJ III, Achenbach SJ, Gebhart JB, Babalola EO, Atkinson EJ, Bharucha AE. Influence of hysterectomy on long-term fracture risk. Fertil Steril 2007; 88: 156-162
21. Melton LJ III, Leibson CL, Good AE, Achenbach SJ, Oberg AL, Khosla S. Long-term fracture risk among women with proven endometriosis. Fertil Steril 2006; 86: 1576-1583
22. Rocca WA, Yawn BP, St Sauver JL, Grossardt BR, Melton LJ III. History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population. Mayo Clin Proc 2012; 87: 1202-1213
23. St Sauver JL, Grossardt BR, Yawn BP, et al. Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system. Int J Epidemiol 2012; 41: 1614-1624
24. St Sauver JL, Grossardt BR, Leibson CL, Yawn BP, Melton LJ III, Rocca WA. Generalizability of epidemiological findings, and public health decisions: an illustration from the Rochester Epidemiology Project. Mayo Clin Proc 2012; 87: 151-160
25. St Sauver JL, Grossardt BR, Yawn BP, Melton LJ III, Rocca WA. Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester Epidemiology Project. Am J Epidemiol 2011; 173: 1059-1068
26. Acmaz G, Aksoy H, Albayrak E, et al. Evaluation of endometrial precancerous lesions in postmenopausal obese women-a high risk group? Asian Pac J Cancer Prev 2014; 15: 195-198
27. Balbi G, Napolitano A, Seguino E, et al. The role of hypertension, body mass index, and serum leptin levels in patients with endometrial hyperplasia during premenopausal period. Clin Exp Obstet Gynecol 2012; 39: 321-325
28. Terry KL, De Vivo I, Hankinson SE, Spiegelman D, Wise LA, Missmer SA. Anthropometric characteristics, and risk of uterine leiomyoma. Epidemiology 2007; 18: 758-763
29. Miedel A, Tegerstedt G, Maehle-Schmidt M, Nyrén O, Hammarström M. Nonobstetric risk factors for symptomatic pelvic organ prolapse. Obstet Gynecol 2009; 113: 1089-1097
30. Fakih M, Cherfan V, Abdallah E. Success rate, quality of life, and descriptive analysis after generalized endometrial ablation in an obese population. Int J Gynaecol Obstet 2011; 113: 120-123
31. Boynton-Jarrett R, Rich-Edwards J, Malspeis S, Missmer SA, Wright R. A prospective study of hypertension, and risk of uterine leiomyomata. Am J Epidemiol 2005; 161: 628-638
32. Faerstein E, Szklo M, Rosenshein NB. Risk factors for uterine leiomyoma: a practice-based case-control study. II. Atherogenic risk factors, and potential sources of uterine irritation. Am J Epidemiol 2001; 153: 11-19
33. Luoto R, Rutanen EM, Auvinen A. Fibroids, and hypertension. A crosssectional study of women undergoing hysterectomy. J Reprod Med 2001; 46: 359-364
34. Templeman C, Marshall SF, Clarke CA, et al. Risk factors for surgically removed fibroids in a large cohort of teachers. Fertil Steril 2009; 92: 1436-1446
35. Sivri N, Yalta T, Sayin C, et al. Evaluation of cardiovascular risk factors in women with uterine leiomyoma: is there a link with atherosclerosis? Balkan Med J 2012; 29: 320-323
36. Moss NS, Benditt EP. Human atherosclerotic plaque cells, and leiomyoma cells. Comparison of in vitro growth characteristics. Am J Pathol 1975; 78: 175-190
37. Nowak RA. Identification of new therapies for leiomyomas: what in vitro studies can tell us. Clin Obstet Gynecol 2001; 44: 327-334
38. Silver MA, Raghuvir R, Fedirko B, Elser D. Systemic hypertension among women with uterine leiomyomata: potential final common pathways of target end-organ remodeling. J Clin Hypertens (Greenwich) 2005; 7: 664-668
39. Haan YC, Oudman I, de Lange ME, et al. Hypertension risk in Dutch women with symptomatic uterine fibroids. Am J Hypertens 2015; 28: 487-492
40. Aksoy Y, Sivri N, Karaoz B, Sayin C, Yetkin E. Carotid intima-media thickness: a new marker of patients with uterine leiomyoma. Eur J Obstet Gynecol Reprod Biol 2014; 175: 54-57
41. Hebert PL, Geiss LS, Tierney EF, Engelgau MM, Yawn BP, McBean AM. Identifying persons with diabetes using Medicare claims data. Am J Med Qual 1999; 14: 270-277
42. Rocca WA, Boyd CM, Grossardt BR, et al. Prevalence of multimorbidity in a geographically defined American population: patterns by age, sex, and race/ethnicity. Mayo Clin Proc 2014; 89: 1336-1349
43. Kjerulff K, Langenberg P, Guzinski G. The socioeconomic correlates of hysterectomies in the United States. Am J Public Health 1993; 83: 106-108